FDA Approved Products
1,302 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
BRAFTOVI
encorafenib
Peak
Pfizer
ORAL · CAPSULE
wild-type BRAF CRCwild-type BRAF NSCLC+4
2018
SMNDA0/100
BRENZAVVY
bexagliflozin
Peak
TheracosBio
ORAL · TABLET
type 2 diabetes mellitustype 1 diabetes mellitus
2023
SMNDA0/100
BREO ELLIPTA
fluticasone furoate and vilanterol trifenatate
Peak
GSK
INHALATION · POWDER
chronic obstructive pulmonary diseaseCOPD+1
2013
NDA0/100
BREXAFEMME
ibrexafungerp citrate
Peak
GSK
ORAL · TABLET
2021
NDA0/100
BREZTRI AEROSPHERE
budesonide, glycopyrrolate, and formoterol fumarate
Peak
AstraZeneca
INHALATION · AEROSOL, METERED
COPDasthma+1
2020
NDA0/100
BRILINTA
ticagrelor
Peak
AstraZeneca
ORAL · TABLET
cardiovascular (CV) deathmyocardial infarction (MI)+6
2011
NDA0/100
BRUKINSA
zanubrutinib
Peak
BeOne Medicines
ORAL · CAPSULE
refractory marginal zone lymphoma (MZL)refractory follicular lymphoma (FL)+5
2019
SMNDA0/100
BRYHALI
halobetasol propionate
Peak
Bausch + Lomb
TOPICAL · LOTION
psoriasis
2018
NDA0/100
BUNAVAIL
buprenorphine hydrochloride; naloxone hydrochloride
Peak
BUCCAL · FILM
2014
NDA0/100
BYDUREON BCISE
exenatide synthetic
Peak
AstraZeneca
SUBCUTANEOUS · SUSPENSION, EXTENDED RELEASE
2017
PeptideNDA0/100
BYFAVO
remimazolam besylate
Peak
Acacia Pharma
INTRAVENOUS · POWDER
2020
NDA0/100
BYLVAY
odevixibat
Peak
Ipsen
ORAL · CAPSULE
pruritus in patients 3 months of ageolder with PFIC+2
2021
NDA0/100
CABENUVA KIT
cabotegravir and rilpivirine
Peak
GSK
INTRAMUSCULAR · SUSPENSION, EXTENDED RELEASE
2021
NDA0/100
CABOMETYX
cabozantinib
Peak
Exelixis
ORAL · TABLET
older with locally advancedmetastatic differentiated thyroid cancer (DTC)+8
2016
SMNDA0/100
CALCIUM GLUCONATE
calcium gluconate
Peak
Fresenius Kabi
INTRAVENOUS · SOLUTION
2017
NDA0/100
CALCIUM GLUCONATE IN SODIUM CHLORIDE
calcium gluconate
Peak
R-Pharm US
INTRAVENOUS · SOLUTION
2018
NDA0/100
CALCIUM GLUCONATE IN SODIUM CHLORIDE
calcium gluconate
Peak
Fresenius Kabi
INTRAVENOUS · SOLUTION
2017
NDA0/100
CALDOLOR
ibuprofen
Peak
Cumberland Pharmaceuticals
INTRAVENOUS · SOLUTION
older for the: Management of mild to moderate painthe management of moderate to severe pain
2009
SMNDA0/100
CALQUENCE
acalabrutinib
Peak
AstraZeneca
ORAL · CAPSULE
small lymphocytic lymphoma (SLL)lymphoma+1
2017
SMNDA0/100
CALQUENCE
acalabrutinib
Peak
AstraZeneca
ORAL · TABLET
small lymphocytic lymphoma (SLL)lymphoma+1
2022
SMNDA0/100
CAMCEVI KIT
leuprolide
Peak
Accord Biopharma
SUBCUTANEOUS · EMULSION
prostate cancer
2021
NDA0/100
CAMZYOS
mavacamten
Peak
Bristol Myers Squibb
ORAL · CAPSULE
symptoms
2022
NDA0/100
CAPLYTA
lumateperone
Peak
Intra-Cellular Therapies
ORAL · CAPSULE
schizophreniadepression
2019
NDA0/100
CARNEXIV
carbamazepine
Peak
INTRAVENOUS · SOLUTION
the treatment of the pain associated with true trigeminal neuralgiaEpilepsy
2016
NDA0/100